Loading…

Clinical management of amyloid cardiomyopathy

Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review,...

Full description

Saved in:
Bibliographic Details
Published in:Heart failure reviews 2022-09, Vol.27 (5), p.1549-1557
Main Authors: Kim, Morris M., Kolseth, Clinton M., Carlson, Dayna, Masri, Ahmad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03
cites cdi_FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03
container_end_page 1557
container_issue 5
container_start_page 1549
container_title Heart failure reviews
container_volume 27
creator Kim, Morris M.
Kolseth, Clinton M.
Carlson, Dayna
Masri, Ahmad
description Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.
doi_str_mv 10.1007/s10741-021-10159-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2568597984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2568597984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOI7-AVcFN26iN4_2pksZfMGAG12HNE3HDm0zJh2G_nujFQQXru5ZfOdw-Qi5ZHDDAPA2MkDJKHBGGbC8pIcjsmA5CoqC8-OUheJUMomn5CzGLQDIUsKC0FXXDq01XdabwWxc74Yx801m-qnzbZ1ZE-rW95PfmfF9Oicnjemiu_i5S_L2cP-6eqLrl8fn1d2aWq74SPNKGC4aBg1aWVmJaBW4plKCoQPO6wprDlVtS5SWsapALjCv8oQ1StUgluR63t0F_7F3cdR9G63rOjM4v4-a54XKSyyVTOjVH3Tr92FI32mOIIoCoVCJ4jNlg48xuEbvQtubMGkG-sugng3qZFB_G9SHVBJzKSZ42LjwO_1P6xPLfXKu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703667068</pqid></control><display><type>article</type><title>Clinical management of amyloid cardiomyopathy</title><source>Springer Link</source><creator>Kim, Morris M. ; Kolseth, Clinton M. ; Carlson, Dayna ; Masri, Ahmad</creator><creatorcontrib>Kim, Morris M. ; Kolseth, Clinton M. ; Carlson, Dayna ; Masri, Ahmad</creatorcontrib><description>Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.</description><identifier>ISSN: 1382-4147</identifier><identifier>EISSN: 1573-7322</identifier><identifier>DOI: 10.1007/s10741-021-10159-w</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Amyloid ; Amyloidosis ; Beta blockers ; Cardiac arrhythmia ; Cardiology ; Cardiomyopathy ; Congestive heart failure ; Diuretics ; Drug dosages ; Enzymes ; Heart failure ; Hemodynamics ; Hospitalization ; Hypertension ; Hypotension ; Medicine ; Medicine &amp; Public Health ; Orthostatic hypotension ; Pulmonary arteries ; Stroke ; Thromboembolism</subject><ispartof>Heart failure reviews, 2022-09, Vol.27 (5), p.1549-1557</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03</citedby><cites>FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03</cites><orcidid>0000-0002-8621-1911</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids></links><search><creatorcontrib>Kim, Morris M.</creatorcontrib><creatorcontrib>Kolseth, Clinton M.</creatorcontrib><creatorcontrib>Carlson, Dayna</creatorcontrib><creatorcontrib>Masri, Ahmad</creatorcontrib><title>Clinical management of amyloid cardiomyopathy</title><title>Heart failure reviews</title><addtitle>Heart Fail Rev</addtitle><description>Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.</description><subject>Amyloid</subject><subject>Amyloidosis</subject><subject>Beta blockers</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Congestive heart failure</subject><subject>Diuretics</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Heart failure</subject><subject>Hemodynamics</subject><subject>Hospitalization</subject><subject>Hypertension</subject><subject>Hypotension</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Orthostatic hypotension</subject><subject>Pulmonary arteries</subject><subject>Stroke</subject><subject>Thromboembolism</subject><issn>1382-4147</issn><issn>1573-7322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMoOI7-AVcFN26iN4_2pksZfMGAG12HNE3HDm0zJh2G_nujFQQXru5ZfOdw-Qi5ZHDDAPA2MkDJKHBGGbC8pIcjsmA5CoqC8-OUheJUMomn5CzGLQDIUsKC0FXXDq01XdabwWxc74Yx801m-qnzbZ1ZE-rW95PfmfF9Oicnjemiu_i5S_L2cP-6eqLrl8fn1d2aWq74SPNKGC4aBg1aWVmJaBW4plKCoQPO6wprDlVtS5SWsapALjCv8oQ1StUgluR63t0F_7F3cdR9G63rOjM4v4-a54XKSyyVTOjVH3Tr92FI32mOIIoCoVCJ4jNlg48xuEbvQtubMGkG-sugng3qZFB_G9SHVBJzKSZ42LjwO_1P6xPLfXKu</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Kim, Morris M.</creator><creator>Kolseth, Clinton M.</creator><creator>Carlson, Dayna</creator><creator>Masri, Ahmad</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8621-1911</orcidid></search><sort><creationdate>20220901</creationdate><title>Clinical management of amyloid cardiomyopathy</title><author>Kim, Morris M. ; Kolseth, Clinton M. ; Carlson, Dayna ; Masri, Ahmad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amyloid</topic><topic>Amyloidosis</topic><topic>Beta blockers</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Congestive heart failure</topic><topic>Diuretics</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Heart failure</topic><topic>Hemodynamics</topic><topic>Hospitalization</topic><topic>Hypertension</topic><topic>Hypotension</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Orthostatic hypotension</topic><topic>Pulmonary arteries</topic><topic>Stroke</topic><topic>Thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Morris M.</creatorcontrib><creatorcontrib>Kolseth, Clinton M.</creatorcontrib><creatorcontrib>Carlson, Dayna</creatorcontrib><creatorcontrib>Masri, Ahmad</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart failure reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Morris M.</au><au>Kolseth, Clinton M.</au><au>Carlson, Dayna</au><au>Masri, Ahmad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical management of amyloid cardiomyopathy</atitle><jtitle>Heart failure reviews</jtitle><stitle>Heart Fail Rev</stitle><date>2022-09-01</date><risdate>2022</risdate><volume>27</volume><issue>5</issue><spage>1549</spage><epage>1557</epage><pages>1549-1557</pages><issn>1382-4147</issn><eissn>1573-7322</eissn><abstract>Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s10741-021-10159-w</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8621-1911</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1382-4147
ispartof Heart failure reviews, 2022-09, Vol.27 (5), p.1549-1557
issn 1382-4147
1573-7322
language eng
recordid cdi_proquest_miscellaneous_2568597984
source Springer Link
subjects Amyloid
Amyloidosis
Beta blockers
Cardiac arrhythmia
Cardiology
Cardiomyopathy
Congestive heart failure
Diuretics
Drug dosages
Enzymes
Heart failure
Hemodynamics
Hospitalization
Hypertension
Hypotension
Medicine
Medicine & Public Health
Orthostatic hypotension
Pulmonary arteries
Stroke
Thromboembolism
title Clinical management of amyloid cardiomyopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T12%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20management%20of%20amyloid%20cardiomyopathy&rft.jtitle=Heart%20failure%20reviews&rft.au=Kim,%20Morris%20M.&rft.date=2022-09-01&rft.volume=27&rft.issue=5&rft.spage=1549&rft.epage=1557&rft.pages=1549-1557&rft.issn=1382-4147&rft.eissn=1573-7322&rft_id=info:doi/10.1007/s10741-021-10159-w&rft_dat=%3Cproquest_cross%3E2568597984%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282t-5b3a23f10f7c4bc477c80efb8317e022db7d20bdc974c11b672375b57c8f88d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2703667068&rft_id=info:pmid/&rfr_iscdi=true